Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Pradat

Showing results (1-10 of 109) with videos related to

Pageof 11
Sort By:
Viruses|October 11, 2018
Epidemiology and Elimination of HCV-Related Liver DiseasePierre Pradat, Victor Virlogeux, Eric Trépo
Gastroenterologie Clinique Et Biologique|February 11, 2004
[Assessment of quality of life in chronic hepatitis C: effect of treatment]Hervé Desmorat, Jean-Marc Combis, Pierre Pradat
Digestive Diseases (Basel, Switzerland)|July 11, 2015
Antiviral Therapy in Patients with Hepatitis C Virus-Induced CirrhosisFrançois Bailly, Pierre Pradat, Victor Virlogeux, et al.
Expert Review of Anti-Infective Therapy|April 10, 2010
Management of nonresponsive hepatitis CFrançois Bailly, Si Nafa Si Ahmed, Pierre Pradat, et al.
The British Journal of Ophthalmology|September 12, 2020
Diagnostic value of lymphopaenia and elevated serum ACE in patients with uveitisPhilippine Cotte, Pierre Pradat, Laurent Kodjikian, et al.
Journal of Geriatric Oncology|December 1, 2018
Free flap head and neck reconstruction: Feasibility in older patientsAurélie Parsemain, Pierre Philouze, Pierre Pradat, et al.
Vaccine|June 17, 2008
Enhancement of neutralizing humoral response of DNA vaccine against duck hepatitis B virus envelope protein by co-delivery of cytokine genesFadi Saade, Thierry Buronfosse, Pierre Pradat, et al.
Pediatric Nephrology (Berlin, Germany)|March 29, 2022
Nephrocalcinosis in very low birth weight infants: incidence, associated factors, and natural courseJeanne Fayard, Pierre Pradat, Sylvie Lorthois, et al.
Antiviral Therapy|August 5, 2008
Prediction of sustained virological response by ribavirin plasma concentration at week 4 of therapy in hepatitis C virus genotype 1 patientsMarianne Maynard, Pierre Pradat, Marie-Claude Gagnieu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 16, 2007
Progression to cirrhosis in hepatitis C patients: an age-dependent processPierre Pradat, Nicolas Voirin, Hans Ludger Tillmann, et al.
Pageof 11

Showing results (1-10 of 109) with videos related to

Sort By:
Pageof 11
Viruses|October 11, 2018
Epidemiology and Elimination of HCV-Related Liver DiseasePierre Pradat, Victor Virlogeux, Eric Trépo
Gastroenterologie Clinique Et Biologique|February 11, 2004
[Assessment of quality of life in chronic hepatitis C: effect of treatment]Hervé Desmorat, Jean-Marc Combis, Pierre Pradat
Digestive Diseases (Basel, Switzerland)|July 11, 2015
Antiviral Therapy in Patients with Hepatitis C Virus-Induced CirrhosisFrançois Bailly, Pierre Pradat, Victor Virlogeux, et al.
Expert Review of Anti-Infective Therapy|April 10, 2010
Management of nonresponsive hepatitis CFrançois Bailly, Si Nafa Si Ahmed, Pierre Pradat, et al.
The British Journal of Ophthalmology|September 12, 2020
Diagnostic value of lymphopaenia and elevated serum ACE in patients with uveitisPhilippine Cotte, Pierre Pradat, Laurent Kodjikian, et al.
Journal of Geriatric Oncology|December 1, 2018
Free flap head and neck reconstruction: Feasibility in older patientsAurélie Parsemain, Pierre Philouze, Pierre Pradat, et al.
Vaccine|June 17, 2008
Enhancement of neutralizing humoral response of DNA vaccine against duck hepatitis B virus envelope protein by co-delivery of cytokine genesFadi Saade, Thierry Buronfosse, Pierre Pradat, et al.
Pediatric Nephrology (Berlin, Germany)|March 29, 2022
Nephrocalcinosis in very low birth weight infants: incidence, associated factors, and natural courseJeanne Fayard, Pierre Pradat, Sylvie Lorthois, et al.
Antiviral Therapy|August 5, 2008
Prediction of sustained virological response by ribavirin plasma concentration at week 4 of therapy in hepatitis C virus genotype 1 patientsMarianne Maynard, Pierre Pradat, Marie-Claude Gagnieu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 16, 2007
Progression to cirrhosis in hepatitis C patients: an age-dependent processPierre Pradat, Nicolas Voirin, Hans Ludger Tillmann, et al.
Pageof 11